Qnovia, Inc. (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- May 30, 2025
- Vertical
- Healthcare
- Funding URL
- View Funding Page
- Funding Amount:
- $16,000,000
Company Info
- Company Description
- Qnovia, Inc. is focused on developing innovative therapies for smoking cessation, with its lead asset being the RespiRx™ nicotine inhaler, designed to assist individuals in quitting smoking.
- Market
- Smoking Cessation
- Location
- USA